Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | ESR1 | P03372 | 2/20 | 0.37 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.34 |
| ▸ | MEN1 | O00255 | 2/20 | 0.34 |
| ▸ | MAPT | P10636 | 2/20 | 0.34 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 2/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.32 |
| ▸ | MITF | O75030 | 1/20 | 0.32 |
| ▸ | NSD2 | O96028 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | CASP3 | P42574 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL565971 | 0.90 | CA2 (0.37) | ALDH1A1KDM4ESMN1; SMN2GAAKMT2A | |
| SCHEMBL565303 | 0.81 | ALDH1A1 (0.40) | ALDH1A1KDM4ESMN1; SMN2GAAESR1 | |
| SCHEMBL564549 | 0.78 | ALDH1A1 (0.45) | ALDH1A1KDM4ESMN1; SMN2GAAESR1 | |
| SCHEMBL564566 | 0.75 | ALDH1A1 (0.45) | ALDH1A1KDM4ESMN1; SMN2GAAESR1 | |
| SCHEMBL1276539 | 0.75 | CA2 (0.56) | ALDH1A1ESR1ESR2CYP3A4KMT2A | |
| SCHEMBL2363598 | 0.72 | CA2 (0.41) | ALDH1A1KDM4ESMN1; SMN2GAAKMT2A | |
| SCHEMBL564626 | 0.72 | GABRA1 (0.48) | ALDH1A1KDM4ESMN1; SMN2GAAKMT2A | |
| SCHEMBL8519281 | 0.70 | CCNA2 (0.40) | ALDH1A1KDM4ESMN1; SMN2GAACYP3A4 | |
| SCHEMBL565964 | 0.70 | ESR1 (0.43) | ALDH1A1KDM4ESMN1; SMN2GAAESR1 | |
| SCHEMBL442352 | 0.70 | CA2 (0.68) | ALDH1A1SMN1; SMN2GAAESR1ESR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8674029-B2 | Method of preparing stabilized polymeric systems using polymeric peroxides | Sunocs LLC (US) | 2014-03-18 | — | — | US | disclosed |
| US-20120035307-A1 | PROCESS FOR MAKING STABLIZED POLYMERIC SYSTEMS WITH NANOSTRUCTURES | SONG CHENGQIAN (US) | 2012-02-09 | — | — | US | disclosed |
| US-20120035315-A1 | METHOD OF PREPARING STABLIZED POLYMERIC SYSTEMS USING POLYMERIC PEROXIDES | SONG CHENGQIAN (US) | 2012-02-09 | — | — | US | disclosed |
| US-7498467-B2 | Antioxidant and bisaminophenol derivative | IDEMITSU KOSAN CO., LTD. (JP) | 2009-03-03 | — | — | US | disclosed |
| US-20080161608-A1 | ANTIOXIDANT AND BISAMINOPHENOL DERIVATIVE | IDEMITSU KOSAN CO., LTD. (JP) | 2008-07-03 | — | — | US | disclosed |
| US-20060208227-A1 | Antioxidant and bisaminophenol derivative | IDEMITSU LOSAN CO., LTD (JP) | 2006-09-21 | — | — | US | disclosed |
| EP-1612254-A1 | ANTIOXIDANT AND BISAMINOPHENOL DERIVATIVE | IDEMITSU KOSAN COMPANY LIMITED (JP) | 2006-01-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080161608-A1 | ANTIOXIDANT AND BISAMINOPHENOL DERIVATIVE | CBR1, CBR3, HMOX1 | ALDH1A1 204/4885KDM4E 3369/4885SMN1; SMN2 3254/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.